- Home
- KALV vs NPFD Comparison
KALV vs NPFD Comparison
Compare KALV & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- NPFD
- Stock Information
- Founded
- KALV N/A
- NPFD 2021
- Country
- KALV United States
- NPFD United States
- Employees
- KALV N/A
- NPFD N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- NPFD Trusts Except Educational Religious and Charitable
- Sector
- KALV Health Care
- NPFD Finance
- Exchange
- KALV Nasdaq
- NPFD Nasdaq
- Market Cap
- KALV 523.1M
- NPFD 456.7M
- IPO Year
- KALV N/A
- NPFD N/A
- Fundamental
- Price
- KALV $11.18
- NPFD $19.18
- Analyst Decision
- KALV Strong Buy
- NPFD
- Analyst Count
- KALV 4
- NPFD 0
- Target Price
- KALV $29.00
- NPFD N/A
- AVG Volume (30 Days)
- KALV 247.5K
- NPFD 64.7K
- Earning Date
- KALV 12-05-2024
- NPFD 01-01-0001
- Dividend Yield
- KALV N/A
- NPFD 6.28%
- EPS Growth
- KALV N/A
- NPFD N/A
- EPS
- KALV N/A
- NPFD N/A
- Revenue
- KALV N/A
- NPFD N/A
- Revenue This Year
- KALV N/A
- NPFD N/A
- Revenue Next Year
- KALV $539.64
- NPFD N/A
- P/E Ratio
- KALV N/A
- NPFD N/A
- Revenue Growth
- KALV N/A
- NPFD N/A
- 52 Week Low
- KALV $7.21
- NPFD $14.50
- 52 Week High
- KALV $16.88
- NPFD $18.07
- Technical
- Relative Strength Index (RSI)
- KALV 46.78
- NPFD 61.52
- Support Level
- KALV $10.78
- NPFD $18.68
- Resistance Level
- KALV $12.12
- NPFD $18.98
- Average True Range (ATR)
- KALV 0.72
- NPFD 0.19
- MACD
- KALV -0.07
- NPFD 0.02
- Stochastic Oscillator
- KALV 41.20
- NPFD 100.00
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About NPFD Nuveen Variable Rate Preferred & Income Fund
Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.